Con to the question "Should Animals Be Used for Scientific or Commercial Testing?"
"Aside from the ethical issues they pose—inflicting both physical pain as well as psychological distress and suffering on large numbers of sentient creatures—animal tests are time- and resource-intensive, restrictive in the number of substances that can be tested, provide little understanding of how chemicals behave in the body, and in many cases do not correctly predict real-world human reactions. Similarly, health scientists are increasingly questioning the relevance of research aimed at 'modeling' human diseases in the laboratory by artificially creating symptoms in other animal species.
Trying to mirror human diseases or toxicity by artificially creating symptoms in mice, dogs or monkeys has major scientific limitations that cannot be overcome. Very often the symptoms and responses to potential treatments seen in other species are dissimilar to those of human patients. As a consequence, nine out of every 10 candidate medicines that appear safe and effective in animal studies fail when given to humans. Drug failures and research that never delivers because of irrelevant animal models not only delay medical progress, but also waste resources and risk the health and safety of volunteers in clinical trials."
Organizations/VIPs/Others Individuals and organizations that do not fit into the other star categories.
"Humane Society International (HSI) extends the work of The Humane Society of the United States around the globe to promote the human-animal bond, protect street animals, support farm animal welfare, stop wildlife abuse, curtail and eliminate painful animal testing, and confront cruelty to animals in all of its forms."
"...Humane Society International has worked since 1992 to create a humane and sustainable world for all animals, including people, through education, advocacy, and the promotion of respect and compassion."
Humane Society International brochure, hsi.org, 2012
501(c)(3) nonprofit corporation
$9,575,995 (total expenses from 2012 Form 990)
Andrew Rowan, PhD, President and CEO
# of Offices:
One (headquarters in Washington, DC) and six affiliates